Skip to content
Agentic OS
Menu

Intelligence / Healthtech / FDA 510(k) Clearances / Traferox Technologies, Inc.

Approvalsdevice cleared16 Sept 2026

Traferox Technologies, Inc.

16 Sept 2026: Device cleared · X°Port Heart Preservation System. Recorded in the openFDA device 510(k) data.

View the source record

Decided
16 Sept 2026
Device
X°Port Heart Preservation System
Specialty
Gastroenterology, Urology
Country
Canada
Location
Mississauga
Clearance type
Traditional
510(k) number
K261913
Submitted
2026-06-08
What this signal means

A clearance starts commercialisation: distribution, reimbursement, software and sales hires.

  1. 268 added in the 30 days to 9 Nov 2026.
  2. Cardiovascular leads with 122 clearances, then Radiology (107).
Reach them with AOS

Find the decision makers at Traferox Technologies, Inc.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

Across AOS Research

Other records for Traferox Technologies, Inc. in our registers.

More in Gastroenterology, Urology

FDA 510(k) Clearances

See all

Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.